Aims and Scope of the Journal

 International Journal of Pharmacy and Engineering (IJPE) presents papers which describe innovative research spanning around the physical, chemical and engineering aspects of pharmaceutical sciences. Papers incorporating the concepts of physical pharmacy, novel biocompatible materials, drug delivery technology and devices as applied in drugs and pharmaceuticals, engineered delivery design, scaling up and pharmaceutical process engineering in addition to tissue engineering and molecular imaging are  welcome  for publications nin this journal. IJPE is a quarterly publication and the target audience and contributors will comprise key personnel from academic, research and pharmaceutical cum related industry. The journal will be a forum for in-depth discussion to promote novel technologies and avant-garde solutions to meet the emerging challenges in the fields of engineering sciences and/or pharmaceuticals.

Current emphasis of the journal will primarily include:

 pharmaceutical process and product development 

 micro/nano scaling of drug candidates or drug carrier systems

 regulatory issues pertaining to drug delivery including micro- and nano-drug delivery systems

 toxicity evaluation  of novel drug delivery based products 

 pharmaceutical biotechnology

 pre-clinical and clinical drug evaluation

 pharmaceutical analysis

 new drug discovery

 research related to various aspects of herbal drugs

 nutraceuticals and probiotics

Original research articles that are interdisciplinary in nature and incorporate the disciplines of physical/chemical/engineering sciences interrelated with the disciplines of molecular and human biology are also within the scope of this journal.

Scientific commentaries and review articles are generally by invitation but any proposals are welcome to be submitted to the Editor-in-Chief for prior approval. Proceedings of scientific meetings may be published as special issues or supplements to the Journal. Manuscripts submitted to the Journal are only accepted on the understanding that:

(a) they are subject to editorial review (generally by two independent referees); 

(b) they have not been, and will not be, published in whole or in part in any other journal; 

(c) the recommended guidelines for the use of experimental animals and human subjects have been adhered to and approved by an appropriate Institutional agency.